The Benefits of Clinical Trials for Triple Negative Breast Cancer

Listen Now

Topics Covered

• The Treatment of Triple Negative Breast Cancer
• Why Clinical Trials Are Important as a Treatment Option for Triple Negative Breast Cancer
• What Happens in a Clinical Trial
• Stages of Clinical Trials
• New Research in the Treatment of Triple Negative Breast Cancer (TNBC)
• Investigational New Drugs in Clinical Trials
• The Meaning of Informed Consent
• Benefits & Risks of Participation
• How & Where Clinical Trials are Conducted
• How to Participate in Clinical Trials
• Specific Questions to Ask Your Health Care Team about Clinical Trials
• Guidelines to Prepare for Telehealth/Telemedicine Appointments, including Technology, Prepared List of Questions & Discussion of OpenNotes
• Accessing Resources for Clinical Trials
• Questions for Our Panel of Experts

Our Panel of Experts

Antoinette R. Tan, MD, MHSc, FACP, FASCO

Chief, Section of Breast Medical Oncology, Director, Phase I Program, Chair, Department of Solid Tumor Oncology and Investigational Therapeutics; Levine Cancer Institute; Clinical Professor, Department of Internal Medicine, Section on Hematology and Oncology, Wake Forest University School of Medicine; Atrium Health

Wade Smith, MD

Breast Cancer Specialist, Assistant Clinical Professor, Department of Medical Oncology & Therapeutics Research, City of Hope, Newport Beach, California

Melissa Berry

Board Chair, Triple Negative Breast Cancer Foundation®; Triple Negative Breast Cancer Thriver; Founder, Cancer Fashionista

Marissa Fors, MSW

Director of Specialized Programs, CancerCare

Brochure

You can download the brochure for this workshop

Workshop Date

This workshop was originally recorded on January 10, 2024.